Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 308
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00433563 | Concurrent Once Daily Versus Twice Daily Radiotherapy for Limited Stage Small Cell Lung Cancer | ||
| NCT00863733 | Study of DMXAA (Now Known as ASA404) in Solid Tumors | ||
| NCT01616238 | A Study for Older Adults With Acute Lymphoblastic Leukaemia | ||
| NCT02761915 | A Phase I Trial of Anti-GD2 T-cells (1RG-CART) | ||
| NCT06380816 | A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer | ||
| NCT04455815 | A Trial Looking at the Use of Camostat in People Who Have Tested Positive for Coronavirus (COVID-19) (SPIKE-1) | ||
| NCT05770102 | DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition | ||
| NCT05770037 | DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers | ||
| NCT03028766 | WEE1 Inhibitor with Cisplatin and Radiotherapy: a Trial in Head and Neck Cancer | ||
| NCT00678327 | Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma | ||
| NCT00027664 | Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer | ||
| NCT03415854 | Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD) | ||
| NCT00082927 | Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain | ||
| NCT05082259 | ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab | ||
| NCT00755885 | Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer | ||
| NCT00993655 | Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer | ||
| NCT00275132 | Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | ||
| NCT05537844 | Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma | ||
| NCT00554775 | WBRT & Erlotinib in Advanced NSCLC and Brain Metastases | ||
| NCT01233492 | Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme | ||
| NCT03371485 | AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer | ||
| NCT04621370 | A Trial of Durvalumab (MEDI 4736) in Combination With Extended Neoadjuvant Regimens in Rectal Cancer | ||
| NCT00509561 | Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer | ||
| NCT03145961 | A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients | ||
| NCT01222221 | Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | ||
| NCT02024009 | Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2 | ||
| NCT03994783 | Transplant Antibody-Mediated Rejection: Guiding Effective Treatments | ||
| NCT07002320 | Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer | ||
| NCT06714630 | The PROSECCA Study, Answering New Questions in Prostate Cancer | ||
| NCT01556841 | The Activity of TroVax® Versus Placebo in Relapsed Asymptomatic Ovarian Cancer | ||
| NCT01166737 | Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer | ||
| NCT05830292 | Use of DRS Probe and Tracking for In-vivo Application | ||
| NCT00749450 | Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer | ||
| NCT03150576 | Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer | ||
| NCT02960620 | Therasphere for Unresectable Primary or Secondary Liver Neoplasia | ||
| NCT01608165 | A Feasibility Study for a Multicentre Randomised Controlled Trial to Compare Surgery With Needle Ablation Techniques in People With Small Renal Masses (4cm) | ||
| NCT00757965 | Study of Genes and the Environment in Patients With Colorectal Cancer in the East Anglia Region of the United Kingdom | ||
| NCT03705507 | International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia | ||
| NCT02330926 | Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy | ||
| NCT03096054 | A Phase I Trial of LY3143921 Hydrate in Solid Tumours | ||
| NCT02768337 | Cambridge Brain Mets Trial 1 | ||
| NCT04118192 | NOSTRA-Feasibility Study: A Study Looking at Ultrasound Guided Biopsies for Breast Cancer | ||
| NCT02758587 | Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1) | ||
| NCT04523116 | Validation of Tie2 as the First Tumour Vascular Response Biomarker for VEGF Inhibitors: VALTIVE1 | ||
| NCT04307576 | A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia | ||
| NCT02071940 | PLX3397 KIT in Acral aNd mucOsal Melanoma | ||
| NCT02664935 | National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer | ||
| NCT00032175 | Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | ||
| NCT00595777 | Edinburgh Pain Assessment Tool (EPAT©) Study | ||
| NCT03720041 | Myeloma XIV: Frailty-adjusted Therapy in Transplant Non-Eligible Patients With Newly Diagnosed Multiple Myeloma |
